Genmab A (GMAB) Net Margin (2018 - 2026)

Genmab A's (GMAB) quarterly Net Margin came in at 634.15% in Q1 2026, down 10655.0% YoY from N/an in Q1 2025, and up 193.53% on a QoQ basis from 216.04% in Q3 2025.

Genmab A (GMAB) Net Margin (2018 - 2026) Analysis & Trends

Genmab A (GMAB) has 5 years of Net Margin data on file, last reported at 634.15% in Q1 2026.

  • Quarterly Net Margin fell 10655.0% year-over-year to 634.15% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 202.33% (down 1165.0% YoY) and the FY2025 annual result came in at 25.89%, down 13871.0% from the prior year.
  • Net Margin grew to 634.15% in Q1 2026, from 216.04% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 781.59% in Q1 2024 to a low of 28.58% in Q2 2024.
  • A 3-year average of 378.79% and a median of 218.06% in 2024 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2025 — Net Margin soared 380 bps — and 2026, when it plunged 10655 bps.
  • Tracing GMAB's Net Margin over 3 years: stood at 218.06% in 2024, then dropped by 1 bps to 216.04% in 2025, then soared by 194 bps to 634.15% in 2026.
  • The last three Net Margin figures came in at 634.15% (Q1 2026), 216.04% (Q3 2025), and 32.38% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 Genmab A 2.05 Bn 548.77 Mn 1.07 Bn 26.23%

Historic Data

Download Data
DateValue
Jun 30, 2026 26.23%
Mar 31, 2026 634.15%
Sep 30, 2025 216.04%
Jun 30, 2025 32.38%
Mar 31, 2025 740.70%
Sep 30, 2024 218.06%
Jun 30, 2024 28.58%
Mar 31, 2024 781.59%
Dec 31, 2019 0.00%
Sep 30, 2019 67,248,451,958,178.34%
Dec 31, 2018 0.00%